CME webinar: Screening and Assessment for Suicide Prevention
Sep. 2022Education/Webinars
"September is National Suicide Awareness Month, and you are invited to watch a timely recorded webinar on the topic. Andrei Nemoianu, MD, Regional Medical Director, Community Care Behavioral Health Organization, discusses:
*This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
*Provider is responsible for verifying CME eligibility."
- How to define suicide screening and identify how often it should be used.
- Suicide assessment and when it should be done.
- How to gain greater familiarity with formulating a suicide risk assessment.
- Three suicide screening tools.
- How to locate resources to help develop a policy around suicide screening and assessment.
*This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
*Provider is responsible for verifying CME eligibility."
Recent Announcements
Voluntary nationwide recall: Sucralfate (Nostrum – July)
Nostrum Laboratories, Inc. is recalling all lots of Sucralfate Tablets USP 1 gram. Sucralfate is used for the prevention and treatment of certain stomach ulcers.Jul. 2025Pharmacy Updates
Receive consultations to better support the behavioral health needs of child and adolescent patients
The Telephonic Psychiatric Consultation Service Program (TiPS) is a Pennsylvania HealthChoices program that gives primary care providers access to free, on-demand consultations with child and adolescent psychiatrists, typically within 30 minutes. It is available to providers of children and adolescents who have Pennsylvania Medicaid, Children’s Health Insurance Program, or UPMC Health Plan commercial insurance.Jul. 2025What's New
Voluntary nationwide recall: Sucralfate (Nostrum – July)
Nostrum Laboratories, Inc. is recalling all lots of Sucralfate Tablets USP 1 gram. Sucralfate is used for the prevention and treatment of certain stomach ulcers.Jul. 2025Pharmacy Updates